Joe Hackett

Intent: To raise the priorities of the Chamber Network regarding Ireland’s Presidency of the Council of the EU, including fully implementing RED III permitting (one-stop shops, digital platforms).

Details: Electrification Action Plan and Renewable Energy Directive III permitting implementation

Intent: Discussion and sharing of information relating to the geopolitical situation, specifically concerns surrounding the imposition of trade tariffs by the US. Understanding of the industry case for altering Ireland's position in the European Council relating to the GPL, as well as raising potential subjects for Ireland's EU Presidency agenda.

Details: IPHA Delegation to meet with An Tánaiste on EU health legislation and policy matters (including GPL and Ireland's EU Presidency), as well as the domestic issue of the negotiation of the pricing and supply agreement.

Intent: Highlight the negative impact of tariff increases on investment, supply chains, and market confidence.

Details: Proposed increase in tariffs on EU imports by the United States.

Intent: Emphasise the need to preserve openness and reliability in EU-US trade to support global economic stability.

Details: Strategic importance of the EU-US trade relationship in the global rules-based trading system.

Intent: Enable Irish innovators to access a simplified and cost-effective system for protecting intellectual property.

Details: Support for a referendum on Ireland’s membership in the EU Unified Patent Court.

Intent: To increase policy focus on Ireland's competitiveness as a location for the biopharmaceutical industry::To improve patient access to innovative medicinal products in Ireland

Details: Industry meeting with Tánaiste on biopharmaceutical policy priorities

Intent: (a) Request to Irish Government to take account of the competitiveness of the pharmaceutical industry in Europe and not there dilute or reduce RDP. (b) Take account of the importance of the pharmaceutical industry in competitiveness of EU.

Details: (i) EU General Pharmaceutical Legislation and Irish Government position on Intellectual Property Rights. (ii) EU and Irish competitiveness and the pharmaceutical industry.

Intent: Ensure understanding of Ibec position on EU countermeasures on EU tariffs.

Details: Ibec response to the European Commission Information gathering notice under Regulation (EU) No 654/2014

Intent: (i) The medicines reimbursement system should be designed and resourced to comply with the 2013 Health Act required for HSE decisions within 180 days excluding clock stops. (ii) Request for meeting to discuss IPHA proposals to address delays in the reimbursement system. (iii) Request to present IPHA Timeline data to the Oireachtas Health Committee.

Details: Future Framework Agreement - issues concerning timely reimbursement of medicines in Ireland.

Intent: (i) The medicines reimbursement system should be designed and resourced to comply with the 2013 Health Act required for HSE decisions within 180 days excluding clock stops. (ii) Request for meeting to discuss IPHA proposals to address delays in the reimbursement system. (iii) Request to present IPHA Timeline data to the Oireachtas Health Committee.

Details: Future Framework Agreement - issues concerning timely reimbursement of medicines in Ireland.